1617 related articles for article (PubMed ID: 27041401)
1. Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes.
Trinh BTD; Staerk D; Jäger AK
J Ethnopharmacol; 2016 Jun; 186():189-195. PubMed ID: 27041401
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant and anti-glycation capacities of some medicinal plants and their potential inhibitory against digestive enzymes related to type 2 diabetes mellitus.
Franco RR; da Silva Carvalho D; de Moura FBR; Justino AB; Silva HCG; Peixoto LG; Espindola FS
J Ethnopharmacol; 2018 Apr; 215():140-146. PubMed ID: 29274842
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of α-amylase and α-glucosidase inhibitory potential of Zea mays Linnaeus (Poaceae), Stigma maydis aqueous extract: An in vitro assessment.
Sabiu S; O'Neill FH; Ashafa AOT
J Ethnopharmacol; 2016 May; 183():1-8. PubMed ID: 26902829
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of In Vitro α-Amylase and α-Glucosidase Inhibitory Potentials of 14 Medicinal Plants Constituted in Thai Folk Antidiabetic Formularies.
Somtimuang C; Olatunji OJ; Ovatlarnporn C
Chem Biodivers; 2018 Apr; 15(4):e1800025. PubMed ID: 29460340
[TBL] [Abstract][Full Text] [Related]
5. In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.
Deo P; Hewawasam E; Karakoulakis A; Claudie DJ; Nelson R; Simpson BS; Smith NM; Semple SJ
BMC Complement Altern Med; 2016 Nov; 16(1):435. PubMed ID: 27809834
[TBL] [Abstract][Full Text] [Related]
6. Bioassay-guided fractionation and identification of α-amylase inhibitors from Syzygium cumini leaves.
Poongunran J; Perera HK; Jayasinghe L; Fernando IT; Sivakanesan R; Araya H; Fujimoto Y
Pharm Biol; 2017 Dec; 55(1):206-211. PubMed ID: 27927056
[TBL] [Abstract][Full Text] [Related]
7. Quadruple high-resolution α-glucosidase/α-amylase/PTP1B/radical scavenging profiling combined with high-performance liquid chromatography-high-resolution mass spectrometry-solid-phase extraction-nuclear magnetic resonance spectroscopy for identification of antidiabetic constituents in crude root bark of Morus alba L.
Zhao Y; Kongstad KT; Jäger AK; Nielsen J; Staerk D
J Chromatogr A; 2018 Jun; 1556():55-63. PubMed ID: 29729863
[TBL] [Abstract][Full Text] [Related]
8. α-Amylase inhibitors from an Indonesian medicinal herb, Phyllanthus urinaria.
Gunawan-Puteri MD; Kato E; Kawabata J
J Sci Food Agric; 2012 Feb; 92(3):606-9. PubMed ID: 22095704
[TBL] [Abstract][Full Text] [Related]
9. Antioxidative activity and inhibition of key enzymes linked to type-2 diabetes (α-glucosidase and α-amylase) by Khaya senegalensis.
Ibrahim MA; Koorbanally NA; Islam MS
Acta Pharm; 2014 Sep; 64(3):311-24. PubMed ID: 25296677
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic potential of Catechu via assays for α-glucosidase, α-amylase, and glucose uptake in adipocytes.
Zhang K; Chen XL; Zhao X; Ni JY; Wang HL; Han M; Zhang YM
J Ethnopharmacol; 2022 Jun; 291():115118. PubMed ID: 35202712
[TBL] [Abstract][Full Text] [Related]
11. alpha-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus.
Ali H; Houghton PJ; Soumyanath A
J Ethnopharmacol; 2006 Oct; 107(3):449-55. PubMed ID: 16678367
[TBL] [Abstract][Full Text] [Related]
12. Standardized Emblica officinalis fruit extract inhibited the activities of α-amylase, α-glucosidase, and dipeptidyl peptidase-4 and displayed antioxidant potential.
Majeed M; Majeed S; Mundkur L; Nagabhushanam K; Arumugam S; Beede K; Ali F
J Sci Food Agric; 2020 Jan; 100(2):509-516. PubMed ID: 31487036
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of resveratrol oligomers from the stem bark of Hopea ponga (Dennst.) Mabb. And their antidiabetic effect by modulation of digestive enzymes, protein glycation and glucose uptake in L6 myocytes.
Sasikumar P; Lekshmy K; Sini S; Prabha B; Kumar NA; Sivan VV; Jithin MM; Jayamurthy P; Shibi IG; Radhakrishnan KV
J Ethnopharmacol; 2019 May; 236():196-204. PubMed ID: 30844488
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant, α-Amylase and α-Glucosidase Inhibitory Activities and Potential Constituents of
Quan NV; Xuan TD; Tran HD; Thuy NTD; Trang LT; Huong CT; Andriana Y; Tuyen PT
Molecules; 2019 Feb; 24(3):. PubMed ID: 30744084
[TBL] [Abstract][Full Text] [Related]
15. HPLC-DAD phenolics analysis, α-glucosidase, α-amylase inhibitory, molecular docking and nutritional profiles of Persicaria hydropiper L.
Mahnashi MH; Alqahtani YS; Alyami BA; Alqarni AO; Alqahl SA; Ullah F; Sadiq A; Zeb A; Ghufran M; Kuraev A; Nawaz A; Ayaz M
BMC Complement Med Ther; 2022 Jan; 22(1):26. PubMed ID: 35086537
[TBL] [Abstract][Full Text] [Related]
16. The multi-targets integrated fingerprinting for screening anti-diabetic compounds from a Chinese medicine Jinqi Jiangtang Tablet.
Chang YX; Ge AH; Donnapee S; Li J; Bai Y; Liu J; He J; Yang X; Song LJ; Zhang BL; Gao XM
J Ethnopharmacol; 2015 Apr; 164():210-22. PubMed ID: 25698248
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the antidiabetic potential of
Tan DC; Idris KI; Kassim NK; Lim PC; Safinar Ismail I; Hamid M; Ng RC
Pharm Biol; 2019 Dec; 57(1):345-354. PubMed ID: 31185767
[No Abstract] [Full Text] [Related]
18. ANTI-OXIDATIVE, (α-GLUCOSIDASE AND α-AMYLASE INHIBITORY ACTIVITY OF VITEX DONIANA: POSSIBLE EXPLOITATION IN THE MANAGEMENT OF TYPE 2 DIABETES.
Ibrahim MA; Koorbanally NA; Islam S
Acta Pol Pharm; 2016 Sep; 73(5):1235-1247. PubMed ID: 29638064
[TBL] [Abstract][Full Text] [Related]
19. Fijian medicinal plants and their role in the prevention of Type 2 diabetes mellitus.
Mala P; Khan GA; Gopalan R; Gedefaw D; Soapi K
Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36149310
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetic effects of Syzygium cumini leaves: A non-hemolytic plant with potential against process of oxidation, glycation, inflammation and digestive enzymes catalysis.
Franco RR; Ribeiro Zabisky LF; Pires de Lima Júnior J; Mota Alves VH; Justino AB; Saraiva AL; Goulart LR; Espindola FS
J Ethnopharmacol; 2020 Oct; 261():113132. PubMed ID: 32673709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
